Cerence (CRNC)
(Delayed Data from NSDQ)
$5.35 USD
-0.93 (-14.81%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.39 +0.04 (0.75%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum B VGM
Price, Consensus and EPS Surprise
CRNC 5.35 -0.93(-14.81%)
Will CRNC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CRNC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRNC
Compared to Estimates, Cerence (CRNC) Q2 Earnings: A Look at Key Metrics
Cerence (CRNC) Reports Q2 Loss, Tops Revenue Estimates
CRNC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stay Ahead of the Game With Cerence (CRNC) Q2 Earnings: Wall Street's Insights on Key Metrics
Cerence (CRNC) Boosts In-Car Experience with CaLLM AI Platform
Cerence (CRNC) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for CRNC
What Analysts Are Saying About Cerence Stock
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
Cerence price target lowered by $14 at Craig-Hallum, here's why
Cerence price target lowered by $12 at Wedbush, here's why
Wedbush Reaffirms Their Hold Rating on Cerence (CRNC)